Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ulipristal acetate followed by randomized progestin challenge in women with uterine fibroids and heavy uterine bleeding
2010-018999-25Phase 3Completed
- Sponsor
- PregLem
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Open-label ulipristal acetate then norethisterone acetate with Open-label ulipristal acetate then placebo (2 arms). Primary endpoint: Efficacy. Started May 2010; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2010-018999-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018999-25.